COVID-19 antiviral pill na molnupiravir, ipapamahagi na sa Nobyembre

ni Jasmin Joy Evangelista | October 28, 2021

Nakatakdang ipamahagi ang COVID-19 antiviral pill na molnupiravir ngayong Nobyembre 2021 sa mga ospital na may "compassionate special permits."

Nasa mahigit 300,000 COVID-19 patients sa Pilipinas ang unang tatanggap nito, ayon sa Philippine healthcare products importer na MedEthix.

“A breakthrough drug is coming as MedEthix will launch the first molnupiravir in the country within November, and that’s already next month,” ani MedEthix co-founder Monaliza Salian.

“The CSP applicant doctors or the associations, the hospitals, will dispense molnupiravir to the patients with the description. So we will just confine ourselves with whatever is the requirements of the FDA,” dagdag niya.

Ayon naman kay Pharmaceutical company JackPharma Inc. president Meny Hernandez, twice a day ite-take ng pasyente ang gamot sa loob ng limang araw o depende sa payo ng doktor.

Maaari umanong magkahalaga ito ng P130 hanggang P150 pesos kada capsule.

“I would estimate… it’s probably anywhere between, on the market itself, hopefully, it will be somewhere in the vicinity of a P130 per pill,” ani Hernandez.

Sa panayam naman kay infectious disease expert Dr. Rontgene Solante, makatutulong ang molnupiravir lalo na sa mga senior citizens na may comorbidity para mapigilan ang severe infection ng COVID-19.